AGBL4

AGBL carboxypeptidase 4, the group of M14 carboxypeptidases

Basic information

Region (hg38): 1:48532854-50023954

Links

ENSG00000186094NCBI:84871OMIM:616476HGNC:25892Uniprot:Q5VU57AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AGBL4 gene.

  • not_specified (102 variants)
  • AGBL4-related_disorder (7 variants)
  • not_provided (2 variants)
  • Prostate_cancer (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AGBL4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000032785.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
2
missense
56
clinvar
1
clinvar
3
clinvar
60
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 56 3 3
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AGBL4protein_codingprotein_codingENST00000371839 141491059
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000002480.9961246120301246420.000120
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.322082690.7740.00001483303
Missense in Polyphen86119.940.717051389
Synonymous0.8878596.10.8850.00000490912
Loss of Function2.551428.80.4860.00000165338

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009330.0000933
Ashkenazi Jewish0.00009960.0000994
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.0002300.000221
Middle Eastern0.000.00
South Asian0.000.00
Other0.0001650.000165

dbNSFP

Source: dbNSFP

Function
FUNCTION: Metallocarboxypeptidase that mediates deglutamylation of target proteins. Catalyzes the deglutamylation of polyglutamate side chains generated by post-translational polyglutamylation in proteins such as tubulins. Also removes polyglutamates from the carboxy-terminus of target proteins such as MYLK. Mediates deglutamylation of CGAS, regulating the antiviral activity of CGAS. Acts as a long-chain deglutamylase and specifically shortens long polyglutamate chains, while it is not able to remove the branching point glutamate, a process catalyzed by AGBL5/CCP5. {ECO:0000250|UniProtKB:Q09LZ8}.;
Pathway
Post-translational protein modification;Metabolism of proteins;Carboxyterminal post-translational modifications of tubulin (Consensus)

Recessive Scores

pRec
0.104

Intolerance Scores

loftool
0.503
rvis_EVS
0.62
rvis_percentile_EVS
83.25

Haploinsufficiency Scores

pHI
0.299
hipred
N
hipred_score
0.250
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0654

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Agbl4
Phenotype
immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cellular phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
proteolysis;protein deglutamylation;C-terminal protein deglutamylation;protein side chain deglutamylation;defense response to virus
Cellular component
Golgi apparatus;centriole;cytosol;ciliary basal body
Molecular function
metallocarboxypeptidase activity;zinc ion binding;tubulin binding